Stephen Fawell, Ph.D.
Board Member
C4 Therapeutics, Inc. (CCCC)Personal wealth note: Equibles reports source-backed professional activity and disclosed compensation; it does not estimate personal net worth.
About Stephen Fawell, Ph.D.
Stephen Fawell, Ph.D. is recorded as Board Member at C4 Therapeutics, Inc. (CCCC). C4 Therapeutics, Inc. reported in an 8-K filed September 3, 2024 that Stephen Fawell, Ph.D. was appointed director, effective August 29, 2024.
“On August 29, 2024, the Board of the Company, upon the recommendation of the Nominating and Corporate Governance Committee of the Board (the "NCG Committee"), appointed Stephen Fawell, Ph.D. as a director of the Company and a member of the Science and Technology Committee of the Board.”
Summary generated from SEC filings and earnings-call records held by Equibles.
Affiliation history
Recorded current and former roles; source labels appear when available.
-
Current
2024-08-29–present
Company network
Recorded roles and call appearances connecting this person to public companies.
Leadership on record at C4 Therapeutics, Inc.
Other people whose current roles at this company are on record from its filings.
- Andrew J. Hirsch CEO
- Andrew Phillips CEO
- Ron Cooper Chairman, Board Member
- Kendra R. Adams CFO, Chief Accounting Officer
- Lauren White Chief Accounting Officer
- Mark Mossler Chief Accounting Officer
- William T. McKee Chief Accounting Officer
- Adam S. Crystal Board Member
- Donna Grogan, M.D. Board Member
- Laura Bessen, M.D. Board Member
Recent activity
Earnings-call and investor-event appearances, plus filed executive appointments or departures, newest first.